A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Clinical trial NCT07085091 · RECRUITING
Trial details
- NCT number
- NCT07085091
- Sponsor
- ALX Oncology Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-18
- Primary completion
- 2027-06-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.